VHL is a tumor suppressor and is involved in the VHL-HIF pathway, its loss leading to an overexpression of HIF1 and HIF2, which also leads to VEGF overexpression triggering events such as proliferation, apoptosis and angiogenesis. The gene discussed is VHL; the disease is neoplasm.